Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen.
Animals
Animals, Newborn
Dinoprostone
/ metabolism
Ductus Arteriosus
/ drug effects
Ductus Arteriosus, Patent
/ drug therapy
Hemodynamics
Homeostasis
Humans
Incidence
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
/ physiopathology
Myosin Light Chains
/ metabolism
Oxygen
/ metabolism
Phosphorylation
Prostaglandins
/ metabolism
Vasoconstriction
Vasodilation
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
10
12
2018
accepted:
27
03
2019
revised:
05
03
2019
pubmed:
10
4
2019
medline:
9
7
2020
entrez:
10
4
2019
Statut:
ppublish
Résumé
The ductus arteriosus (DA) is probably the most intriguing vessel in postnatal hemodynamic transition. DA patency in utero is an active state, in which prostaglandin E
Identifiants
pubmed: 30965358
doi: 10.1038/s41390-019-0387-7
pii: 10.1038/s41390-019-0387-7
doi:
Substances chimiques
Myosin Light Chains
0
Prostaglandins
0
Dinoprostone
K7Q1JQR04M
Oxygen
S88TT14065
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM